Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Adcock (London, United Kingdom). New Drugs for COPD: the current status. Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD

Member's Comments

No comment yet.

Related content which might interest you: The New Zealand respiratory health survey- rationale, methodology and response rate Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013 Influence of smoking on respiratory function and status of proteinas-inhibitory system in patients COPD Source: International Congress 2014 – Passive smoking, active smoking and COPD Year: 2014 Evaluating the use of the Australian and New Zealand COPD guidelines (The COPD-X Plan) in clinical practice: a user survey Source: Virtual Congress 2020 – Evaluation of knowledge transfer into clinical practice Year: 2020 Nicotine dependence and changes in smoking status among smokers - report from the obstructive lung disease in Northern Sweden COPD study Source: Annual Congress 2013 –COPD and tobacco management Year: 2013 Current and future costs of COPD in the Netherlands Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013 Knowledge of the general population about COPD and its determinants: Current status and recent changes in Spain Source: Annual Congress 2012 - Tobacco dependence and respiratory disease Year: 2012 Late Breaking Abstract - A New study of the Prevalence of COPD in Spain: EPISCAN II Source: International Congress 2019 – COPD: epidemiology and spirometry Year: 2019 Description of smoking status in pulmonary patient in the discharge list Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease Year: 2013 Association between inhaled corticosteroid use in COPD and incidence or worsening of type2 diabetes Source: International Congress 2014 – Markers Year: 2014 The effect of Vitamin D deficiency on lung function in current smoker COPD patients Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Real life distribution of the COPD patients in GOLD groups A to D in German population: DACCORD registry Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 COPD severity analysis according to current evaluation criteria – National survey Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Current opinion: Pharmacological approaches in asthma and COPD Source: Breathe 2009; 6: 24-35 Year: 2009 COPD and depression: Prevalence and interaction Source: International Congress 2014 – Comorbidities Year: 2014 Live from London: Current and future biomarkers in severe asthma Source: ERS Satellite 2018 Year: 2018 Differences in adherence to common inhaled medications in COPD Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Association of vitamin D with current wheeze and lung function in Canadian children Source: Annual Congress 2013 –Preschool wheeze Year: 2013 Effect of aclidinium bromide on dyspnoea and health status in patients with stable COPD: Phase III data by GOLD 2013 classification Source: International Congress 2014 – Asthma and COPD management Year: 2014 Distribution and outcomes of the new Spanish phenotype-based guideline for COPD Source: International Congress 2014 – COPD exacerbations Year: 2014